Evidence map›Paper›PMID 42421915›Full record

ArticleFrontiers in nutrition2026

NRS2002-stratified body composition and laboratory characteristics in hospitalized cancer patients assessed by bioelectrical impedance analysis.

Ping Zhong, Qiong Lai, Nan Luo, Ya Zou, Xueli Du, Ying Zhang

Abstract read
In one paragraph

Article in Frontiers in nutrition, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Ping ZhongDepartment of Oncology, The Third People's Hospital of Chengdu, Chengdu, Sichuan, China.
Qiong LaiDepartment of Oncology, The Third People's Hospital of Chengdu, Chengdu, Sichuan, China.
Nan LuoDepartment of Oncology, The Third People's Hospital of Chengdu, Chengdu, Sichuan, China.
Ya ZouDepartment of Oncology, The Third People's Hospital of Chengdu, Chengdu, Sichuan, China.
Xueli DuDepartment of Oncology, The Third People's Hospital of Chengdu, Chengdu, Sichuan, China.
Ying ZhangDepartment of Oncology, The Third People's Hospital of Chengdu, Chengdu, Sichuan, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: The body composition and laboratory characteristics underlying Nutritional Risk Screening 2002 (NRS2002)-defined nutritional risk in hospitalized patients with cancer remain insufficiently described. Methods: This single-center retrospective cross-sectional study included 998 hospitalized patients with cancer. Nutritional risk was defined as NRS2002 ≥3. Bioelectrical impedance analysis (BIA) parameters and laboratory indicators related to inflammation and nutritional status were compared across NRS2002 categories. Multivariable logistic regression was used to assess adjusted associations between key body composition parameters and nutritional risk after adjustment for age, sex, body mass index, and cancer group. Results: Across increasing NRS2002 categories, extracellular water-to-total body water ratio increased, whereas body mass index decreased. Among laboratory indicators, albumin and hemoglobin tended to decrease, whereas C-reactive protein (CRP) tended to increase. In multivariable analyses, albumin was inversely associated with nutritional risk in the model without CRP (OR = 0.958, 95% CI 0.928-0.989, Conclusion: Laboratory indicators related to inflammation and nutritional status showed more consistent associations with NRS2002-defined nutritional risk than single-time-point BIA-derived body composition parameters. BIA-derived parameters may provide complementary information on body composition, but their interpretation should consider clinical status and the limitations of single-time-point assessment.

Indexed as

bioelectrical impedance analysisbody compositioninflammationnutritional riskNutritional Risk Screening 2002

Identifiers

PMID42421915
PMCPMC13341418

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.